Back to RU Rubric Capital Management LP

ARQTARQT

Showing 8 of 18 quarters

Position history for RURubric Capital Management LP's holdings in Arcutis Biotherapeutics, Inc.

Yes. Rubric Capital Management holds 8,421,577 shares of ARQT (Arcutis Biotherapeutics), worth $222.6M, as of its Q3 2026 13F filing. It increased the position by 150,000 shares (+1.8%) from Q2 2026. Rubric Capital Management has held ARQT since Q2 2022, across 18 quarterly 13F filings. ARQT is 2.1% of Rubric Capital Management's reported 13F portfolio.

Current Value

$222.6M

Current Shares

8.4M

Total Value Change

+$69.8M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
8.4M
+1.8%
$222.6M2.1%$26.43
53
2026-Q2
Unchanged
8.3M
0.0%
$216.9M2.0%$26.22
0
2026-Q1
Unchanged
8.3M
0.0%
$194.9M2.1%$23.56
0
2025-Q4
Decreased
8.3M
-23.1%
$240.2M2.9%$29.04
0
2025-Q3
Unchanged
10.7M
0.0%
$202.6M2.3%$18.85
0
2025-Q2
Decreased
10.7M
-2.0%
$150.7M2.3%$14.02
0
2025-Q1
Unchanged
11M
0.0%
$171.5M3.1%$15.64
0
2024-Q4
Unchanged
11M
0.0%
$152.8M2.0%$13.93
0

Optional analytics helps us improve. How it’s used